Share chart DexCom, Inc.
Extended chart
Simple chart
About DexCom, Inc.
DexCom, Inc., компания по производству медицинского оборудования, занимается проектированием, разработкой и коммерциализацией систем непрерывного мониторинга уровня глюкозы (CGM) в США и за рубежом. Компания предоставляет свои системы для использования людьми с диабетом, а также для использования поставщиками медицинских услуг. more details| IPO date | 2005-04-14 |
|---|---|
| ISIN | US2521311074 |
| Industry | Health Care Equipment & Supplies |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://www.dexcom.com |
| Цена ао | 72.13 |
| Change price per day: | +1.24% (70.78) |
|---|---|
| Change price per week: | +4.51% (68.57) |
| Change price per month: | -2.57% (73.55) |
| Change price per 3 month: | -18.29% (87.7) |
| Change price per half year: | -2.42% (73.44) |
| Change price per year: | -48.08% (138.01) |
| Change price per 3 year: | -77% (311.52) |
| Change price per 5 year: | -82.9% (418.95) |
| Change price per 10 year: | +261.19% (19.84) |
| Change price per year to date: | -8.13% (78) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Vanguard Group Inc | 44467463 | 11.53 |
| Blackrock Inc. | 32726186 | 8.49 |
| Baillie Gifford and Company | 16520313 | 4.29 |
| State Street Corporation | 16198598 | 4.2 |
| Capital Research Global Investors | 15296032 | 3.97 |
| Sands Capital Management, LLC | 15058806 | 3.91 |
| Capital World Investors | 9278685 | 2.41 |
| Geode Capital Management, LLC | 8917255 | 2.31 |
| FMR, LLC | 8112737 | 2.1 |
| Nuveen Asset Management, LLC | 7492292 | 1.94 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Global X Telemedicine & Digital Health ETF Registered | 1.90937 | 7.26 | 0.28226 |
| iShares Morningstar Mid-Cap Growth ETF | 0.52082 | 458.38 | 0.94237 |
| Harbor Disruptive Innovation ETF | 0.3338 | 29.05 | 0.39896 |
| iShares Morningstar Mid-Cap ETF | 0.25931 | 260.95 | 1.7458 |
| Nationwide Nasdaq-100 Risk-Managed Income ETF | 0.18478 | 21.38 | 0.87606 |
| Fidelity Growth Opportunities ETF | 0.17739 | -1.24 | 0.48881 |
| iShares Morningstar Large-Cap Growth ETF | 0.11488 | 291.4 | 0.5823 |
| iShares Factors US Growth Style ETF | 0.08184 | 7.44 | 0.7035 |
| iShares Morningstar Large-Cap ETF | 0.05543 | 257.57 | 1.41244 |
| Columbia U.S. ESG Equity Income ETF | 0.04668 | -99.18 | 1.44131 |
| 0.37 | 123.3 | 0.89 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Kevin Ronald Sayer | Executive Chairman, CEO & President | 2.22M | 1958 (67 years) |
| Mr. Jereme M. Sylvain | Executive VP, CFO & Chief Accounting Officer | 841.14k | 1980 (45 years) |
| Mr. Jacob Steven Leach | Executive VP & COO | 994.13k | 1978 (47 years) |
| Mr. Sean Christensen | Director of Corporate Affairs & Head of Investor Relations | N/A | |
| Mr. Matthew Dolan | Executive Vice President of Strategy, Corporate Development & Dexcom Labs | N/A | 1981 (44 years) |
| Mr. Girish Naganathan | Executive VP & CTO | 423.92k | 1977 (48 years) |
| Mr. Michael Jon Brown | Executive VP & Chief Legal Officer | 954.46k | 1970 (55 years) |
| Ms. Leverne Marsh | Executive Vice President of Marketing | N/A | |
| Ms. Teri Lawver | Executive VP & Chief Commercial Officer | 1967 (58 years) | |
| Stacey Stewart | Senior VP & Chief Information Officer |
Address: United States, San Diego. CA, 6340 Sequence Drive - open in Google maps, open in Yandex maps
Website: https://www.dexcom.com
Website: https://www.dexcom.com
